Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. May 7, 2022; 28(17): 1830-1844
Published online May 7, 2022. doi: 10.3748/wjg.v28.i17.1830
Table 3 Clinical features in different subtypes of PIBD in the Asia-Pacific region

IBD subtypes
P value (CD vs UC)
CD, n = 174 (55.9%)
UC, n = 119 (38.3%)
IBD-U, n = 18 (5.8%)
Symptoms at diagnosis (n, column %)
Abdominal pain107 (61.5)53 (44.5)7 (38.9)0.004
Chronic diarrhoea104 (59.8)69 (58.0)10 (55.6)0.760
Bloody diarrhoea60 (34.5)89 (74.8)11 (61.1)< 0.001
Weight loss81 (46.6)44 (37.0)9 (50.0)0.104
Fever66 (37.9)21 (17.6)2 (11.1)< 0.001
Loss of appetite57 (32.8)19 (16.0)6 (33.3)0.001
Malaise/fatigue28 (16.1)8 (6.7)1 (5.6)0.016
Oral ulcers36 (20.7)1 (0.8)0 (0.0)< 0.001
Perianal symptoms (pain/discharge)23 (13.2)3 (2.5)1 (5.6)0.002
Joint pains13 (7.5)6 (5.0)0 (0.0)0.407
Physical signs at diagnosis (n, column %)
Pallor68 (39.1)32 (26.9)5 (27.8)0.031
Hepatomegaly8 (4.6)12 (10.1)2 (11.1)0.067
Abdominal tenderness47 (27.0)15 (12.6)2 (11.1)0.003
Asymptomatic perianal tags25 (14.4)3 (2.5)1 (5.6)0.001
Perianal fissure20 (11.5)2 (1.7)1 (5.6)0.002
Muscle wasting25 (14.4)7 (5.9)1 (5.6)0.022
Arthritis12 (6.9)3 (2.5)0 (0.0)0.095
Erythema nodosum8 (4.6)0 (0.0)0 (0.0)0.018
Anthropometric parameters (SD)
Mean weight Z-score-1.4 (1.7)-1.0 (1.7)-0.7 (2.2)0.110
Mean height Z-score-0.8 (1.5)-0.6 (1.6)-0.6 (2.4)0.583
Growth failure (Height Z-score less than -2) (%)18.416.117.60.907
Mean BMI Z-score-1.5 (1.8)-0.9 (1.7)-0.6 (1.8)0.013
Laboratory investigations at diagnosis (SD)
Mean haemoglobin, g/dL10.6 (1.9)11.0 (2.5)10.9 (1.5)0.221
Mean ESR, mm/hr50.8 (30.5)42.6 (34.4)34.9 (32.2)0.063
Mean C-reactive protein, mg/L54.6 (55.0)20.1 (24.3)7.1 (9.1)< 0.001
Mean albumin, g/dL33.0 (8.7)35.4 (8.4)37.2 (7.1)0.040
Mean ALT, U/L18.5 (20.5)72.7 (162.0)20.4 (13.4)< 0.001
Mean AST, U/L27.0 (32.9)84.2 (170.7)30.5 (10.5)0.001
Mean GGT, U/L38.3 (79.8)126.7 (160.8)30.8 (40.0)< 0.001
Mean faecal calprotectin, μg/g783 (1009.0)583.4 (353.1)593.5 (300.5)0.447